Position in CYTK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$325,425
+$86,897 QoQ
Shares Held
3,820
+5.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#338
of 477 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Meeder Advisory Services, Inc. holds $10,646,226 across 17 Biotechnology names. CYTK ranks #10 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,415 | $3,186,522 | |
| 2 | RPRX |
Royalty Pharma plc
|
19,242 | $1,078,898 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,311 | $817,460 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,922 | $734,512 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
7,660 | $607,361 | |
| 6 | MRNA |
Moderna, Inc.
|
7,734 | $541,612 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,611 | $484,959 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
7,785 | $452,542 |
All Filings in CYTK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $325,425 | 3,820 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $238,528 | 3,619 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $242,023 | 3,809 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||